期刊文献+

miR-4513在胃癌中的表达及临床相关研究

Expression and clinicopathological significance of miR-4513 in gastric carcinoma
下载PDF
导出
摘要 目的:检测microRNA‐4513(miR‐4513)在胃癌中的表达并其相关的临床意义。方法:选取41例胃癌患者的手术标本以及胃癌细胞系HGC27和MGC803,采用实时荧光定量-聚合酶链反应(RT-PCR)方法检测胃癌组织和细胞中miR-4513的表达,分析miR-4513表达与患者临床病理特征的关系,COX回归模型分析影响患者生存期的因素,Kaplan-Meier生存曲线分析miR-4513不同表达水平患者的生存率。结果:HGC27和MGC803胃癌细胞中miR-4513 mRNA表达显著高于GES正常胃粘膜上皮细胞,胃癌组织中miR-4513表达显著高于癌旁组织,差异均有统计学意义(P<0.01)。miR-4513的表达与TNM分期、淋巴结转移及远处转移有关(P<0.05)。多因素分析显示miR-4513可以作为一个独立表示预后的因子,miR-4513高表达组患者的总生存率低于低表达组,差异有统计学意义(P<0.01)。结论:miR-4513可能在胃癌的发生发展中具有一定的促进作用,miR-4513高表达组患者可能预后不良。 Objective:To examine the expression of miR-4513gene in human gastric carcinoma(GC)and explore its clinical significance.Medthods:The expression of miR-4513 in 41 GC tissues and cells was examined by using quantitative real-time PCR.The relationship between miR-4513 expression and clinicopathological features of patients was analyzed.COX regression model was used to analyze the factors affecting the survival of patients,and Kaplan-Meier survival curve was used to analyzethe survival rate of patients with different levels of miR-4513 expression.Results:miR-4513 was highly expressed in gastric cancer cells HGC27 and MGC803 than that in normal gastric mucosa epithelial cells GES.miR-4513 expression in gastric carcinoma tissues was significantly higher than that in adjacent tissues,and the difference was statistically significant(P<0.01).The expression of miR-4513 was correlated with TNM stage,lymph node metastasis and distant metastasis of gastric cancer(P<0.05).Multifactorial analysis showed that miR-4513 may be regarded as a prognostic factorfor survival.The overall survival rate of miR-4513 high-expressed group was lower than that of miR-4513 low-expressed group(P<0.001).Conclusion:miR-4513 may play a role in promoting the development of gastric carcinoma,and patients with high expression of miR-4513 may have a poor prognosis.
作者 刘小兵 施育华 LIU Xiaobing;SHI Yuhua(Department of General Surgery,Affilated Hospital 6 of Natnong University/Yancheng Third People’s Hospital,Jiangsu 224001)
出处 《交通医学》 2022年第2期128-130,共3页 Medical Journal of Communications
基金 江苏省第五期“333工程”科研资助项目(BRA2020213)。
关键词 miR-4513 胃癌 临床病理特征 miR-4513 gastric carcinoma clinicopathological features
  • 相关文献

参考文献2

二级参考文献21

  • 1Muhammed Ashraf Memon,Nick Butler,Breda Memon.The issue of lymphadenectomy during laparoscopic gastrectomy for gastric carcinoma[J].World Journal of Gastrointestinal Oncology,2010,2(2):65-67. 被引量:10
  • 2YUAN YUAN.Art at Its Finest[J].Beijing Review,2010,53(3):16-17. 被引量:2
  • 3Wei-guo Zhu,Da-fu Xua,Jun Pu,Cheng-dong Zong,Tao Li,Guang-zhou Tao,Fu-zhi Ji,Xi-lei Zhou,Ji-hua Han,Cheng-shi Wang,Chang-hua Yu,Jiang-guo Yi,Xi-long Su,Jin-xia Ding.A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection[J]. Radiotherapy and Oncology . 2012 (3)
  • 4Mun Ki Choi,Gwang Ha Kim,Do Youn Park,Geun Am Song,Dong Uk Kim,Dong Yup Ryu,Bong Eun Lee,Jae Hoon Cheong,Mong Cho.Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center experience[J]. Surgical Endoscopy . 2013 (11)
  • 5Andrea Coratti,Mario Annecchiarico,Michele Di Marino,Edoardo Gentile,Francesco Coratti,Pier Cristoforo Giulianotti.Robot-assisted Gastrectomy for Gastric Cancer: Current Status and Technical Considerations[J].World Journal of Surgery.2013(12)
  • 6Benjamin Schmidt,Nicole Look-Hong,Ugwuji N. Maduekwe,Kevin Chang,Theodore S. Hong,Eunice L. Kwak,Gregory Y. Lauwers,David W. Rattner,John T. Mullen,Sam S. Yoon.Noncurative Gastrectomy for Gastric Adenocarcinoma Should only be Performed in Highly Selected Patients[J].Annals of Surgical Oncology.2013(11)
  • 7J. Chen,Z. Tang,X. Dong,S. Gao,H. Fang,D. Wu,D. Xiang,S. Zhang.Radiofrequency ablation for liver metastasis from gastric cancer[J].European Journal of Surgical Oncology.2013(7)
  • 8J.A. Ajani,M. Buyse,M. Lichinitser,V. Gorbunova,G. Bodoky,J.Y. Douillard,S. Cascinu,V. Heinemann,R. Zaucha,A. Carrato,D. Ferry,V. Moiseyenko.Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study[J].European Journal of Cancer.2013
  • 9Florian Lordick,Yoon-Koo Kang,Hyun-Cheol Chung,Pamela Salman,Sang Cheul Oh,Gy?rgy Bodoky,Galina Kurteva,Constantin Volovat,Vladimir M Moiseyenko,Vera Gorbunova,Joon Oh Park,Akira Sawaki,Ilhan Celik,Heiko G?tte,Helena Melezínková,Markus Moehler.Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial[J].Lancet Oncology.2013(6)
  • 10Lei Jiang,Ke‐Hu Yang,Quan‐Lin Guan,Peng Zhao,Yan Chen,Jin‐Hui Tian.Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: A meta‐analysis[J].J Surg Oncol.2013(8)

共引文献175

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部